Savara
SVRA
#6066
Rank
โ‚น106.61 B
Marketcap
โ‚น520.28
Share price
-1.45%
Change (1 day)
125.39%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -โ‚น11.62 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น11.39 Billion a decrease over its 2024 earnings that were of -โ‚น9.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น11.62 Billion1.98%
2025 -โ‚น11.39 Billion23.94%
2024 -โ‚น9.19 Billion75.29%
2023 -โ‚น5.25 Billion43.38%
2022 -โ‚น3.66 Billion-11.31%
2021 -โ‚น4.13 Billion-13.3%
2020 -โ‚น4.76 Billion-36.53%
2019 -โ‚น7.5 Billion13.76%
2018 -โ‚น6.59 Billion105.54%
2017 -โ‚น3.21 Billion34.11%
2016 -โ‚น2.39 Billion-37.43%
2015 -โ‚น3.82 Billion38.81%
2014 -โ‚น2.76 Billion33.62%
2013 -โ‚น2.06 Billion38.49%
2012 -โ‚น1.49 Billion24.59%
2011 -โ‚น1.2 Billion-36.5%
2010 -โ‚น1.88 Billion-3.14%
2009 -โ‚น1.94 Billion-23.28%
2008 -โ‚น2.53 Billion8.52%
2007 -โ‚น2.33 Billion-34.14%
2006 -โ‚น3.54 Billion184.43%
2005 -โ‚น1.25 Billion90.75%
2004 -โ‚น0.66 Billion190.35%
2003 -โ‚น0.23 Billion11.64%
2002 -โ‚น0.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚น21.94 Billion 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น1.74 Billion-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA